Please enable JavaScript
Powered by Benchmark Saransh Kanaujia, Author at Matribhumi Samachar English - Page 52 of 2916
Friday, April 03 2026 | 07:12:23 PM
Home / Saransh Kanaujia (page 52)

Saransh Kanaujia

Saransh Kanaujia is currently editor of Matribhumi Samachar Group. He earlier worked with Hindusthan Samachar News Agency. He is also associated with many organizations.

Eastport Expands Drilling Program at Foley Uranium Project in Botswana Following Completion of Phase 1 Drill Program

Vancouver, British Columbia–(Newsfile Corp. – March 12, 2026) – Eastport Critical Minerals Corp. (TSXV: EVI) (OTCQB: EVIIF) (“Eastport” or the “Company”) is pleased to provide an update on its ongoing exploration activities at the Foley Uranium Project, located immediately north of the Letlhakane uranium deposit in Botswana’s Central District, one of the …

Read More »

Tinka Announces Upgrade to OTCQX

Vancouver, British Columbia–(Newsfile Corp. – March 12, 2026) – Tinka Resources Limited (TSXV: TK) (OTCQX: TKRFF) (“Tinka” or the “Company“) is pleased to announce that it has qualified to upgrade from the OTCQB® Venture Market to the OTCQX® Best Market (the “OTCQX Market” or “OTCQX”). The Company will commence trading today on …

Read More »

Nine Mile Metals Announces Certified Assays from DDH-WD-25-01 of 3.83% CuEq Over 22.65 Meters (39.52 g/t Ag, 0.96 g/t Au, 0.99% Cu, 2.25% Pb, 1.61% Zn) and 4.33% CuEq Over 17.65 Meters (42.5 g/t Ag, 1.01 g/t Au, 1.2% Cu, 2.62% Pb, 2.05% Zn) Including 1.21 g/t Au and 50.33 g/t Ag Over 13.00 Meters

Toronto, Ontario–(Newsfile Corp. – March 12, 2026) – NINE MILE METALS LTD. (CSE: NINE) (OTC Pink: VMSXF) (FSE: KQ9) (the “Company” or “Nine Mile“) is pleased to announce it has received certified assays for drill hole WD-25-01 at the Wedge Mine situated in the renowned Bathurst Mining Camp, New Brunswick …

Read More »

Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease

Park City, Utah–(Newsfile Corp. – March 12, 2026) – Glafabra Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to GT-GLA-S03, its lead cell therapy candidate for classic Fabry disease. To view the full announcement, including downloadable images, bios, and more, click …

Read More »

Excellon Announces Closing of Bought Deal Private Placement and Concurrent Private Placement for Gross Proceeds of Approximately C$21.8 Million

Toronto, Ontario–(Newsfile Corp. – March 12, 2026) – Excellon Resources Inc. (TSXV: EXN) (OTC Pink: EXNRF) (FSE: E4X2) (“Excellon” or the “Company“) is pleased to announce the closing of its previously announced “bought deal” private placement (the “Bought Deal Private Placement“), pursuant to which the Company sold an aggregate of …

Read More »

Brasnova Energy Materials Inc. Appoints Qualified Person and Initiates Sampling Program on the Capela Gold Project, Brazil

Vancouver, British Columbia–(Newsfile Corp. – March 12, 2026) – Brasnova Energy Materials Inc. (TSXV: BEM) (“BEM” or the “Company”) is pleased to announce the engagement of Qualified Person geologist Carlos Henrique Lourenço Bastos to supervise work programs and prepare an independent National Instrument 43-101 (“NI 43-101”) Technical Report for the …

Read More »

Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026

Singapore, Singapore–(Newsfile Corp. – March 12, 2026) – Mobile-health Network Solutions (NASDAQ: MNDR) (“MNDR” or “the Company”), a leading AI HealthTech platform, today announced that, for the first six months of fiscal 2026 ended December 31, 2025, the Company achieved significant improvements in its gross margin and cash position while …

Read More »

AITX’s RAD Announces New Orders Reflecting Ongoing Market Demand

Direct Enterprise Client and Channel Partner Expand with ROSA and RIO Mini Systems Powered by SARA Detroit, Michigan–(Newsfile Corp. – March 12, 2026) – Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the “Company”), a global leader in AI-driven security and productivity solutions, along with its wholly owned subsidiary, Robotic Assistance Devices, Inc. …

Read More »